Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158273 · ClinicalTrials.gov registry record · Phase 2
Medication Development in Alcoholism: Investigating PPAR Agonists
A Phase 2 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02158273 is a Phase 2 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 50 participants.
The verdict
NCT02158273, a Phase 2 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
Interventions
- DRUG Sugar Pill
- DRUG TRICOR (fenofibrate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02158273
The ClinicalTrials.gov registry entry for NCT02158273 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar Pill is the first listed.
NCT02158273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02158273 about?
NCT02158273 is a clinical study titled "Medication Development in Alcoholism: Investigating PPAR Agonists". The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
What is the current status of trial NCT02158273?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2014-05. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02158273?
The interventions under investigation include: Sugar Pill (DRUG), TRICOR (fenofibrate) (DRUG).
Who is sponsoring clinical trial NCT02158273?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.